SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 16.56 |
| Enterprise Value ($M) | 9.14 |
| Book Value ($M) | 7.30 |
| Book Value / Share | 7.06 |
| Price / Book | 2.27 |
| NCAV ($M) | -5.29 |
| NCAV / Share | -5.12 |
| Price / NCAV | -3.13 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.43 |
| Return on Assets (ROA) | -0.87 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.82 |
| Current Ratio | 1.82 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.39 |
| Assets | 20.99 |
| Liabilities | 13.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1.92 |
| Operating Income | -23.44 |
| Net Income | -31.54 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -30.68 |
| Cash from Investing | -0.13 |
| Cash from Financing | 25.04 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Emerald Bioventures, LLC | 5.60 | ||
| 13G | Deep Track Capital, LP | 9.99 | ||
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 0.00 | -100.00 | |
| 13G/A | Nantahala Capital Management, LLC | 4.90 | -93.57 | |
| 13G/A | Great Point Partners Llc | 0.26 | ||
| 13G/A | Point72 Asset Management, L.P. | 0.30 | -99.96 | |
| 13G/A | Caissa Capital Management ltd. | 0.00 | -100.00 | |
| 13D/A | Armistice Capital, Llc | 4.99 | -86.97 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 11,272 | 50,920 | 22.14 | |
| 12,995 | 61,957 | 20.97 | |
| 8,329 | 5,607 | 148.55 | |
| 28,466 | 12,280 | 231.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATNF – 180 Life Sciences Corp. | ATOS – Atossa Therapeutics, Inc. |
| ATXI – Avenue Therapeutics, Inc. | AWH – Aspira Women's Health Inc. |
| AYTU – Aytu BioPharma, Inc. |
Financial data and stock pages provided by
Fintel.io